Schizophrenic stem cells do not differentiate properly into neurons

November 1, 2016
Representative images of neural differentiation from neurospheres treated with the p38 inhibitor SB203580 (1.0 μM). Neurons and astrocytes were visualized by immunocytochemical staining of βIII-tubulin and glial fibrillary acidic protein (GFAP), respectively. Scale bars, 100 μm. Credit: RIKEN

Researchers at the RIKEN Brain Science Institute have used human-induced pluripotent stem cells (hiPSCs) to identify a characteristic of abnormal brain development in schizophrenia. Published in Translational Psychiatry, the study shows how deletion of a specific gene known to be associated with schizophrenia leads to abnormal differentiation of neurons and an imbalance between the number of neurons and astrocytes in the brain.

While many genetic factors contribute to schizophrenia, small deletions of a region on chromosome 22 are thought to pose a particular risk because several genes at that location are involved in the development and function of in the brain. To investigate exactly how brain development is altered in schizophrenia by genetic deletions in this region, the team led by Takeo Yoshikawa took advantage of modern stem-cell technology. The researchers produced hiPSCs from people without schizophrenia and from patients with schizophrenia who had this deletion, and compared how the different hiPSCs developed into neurons.

Explains Yoshikawa, "When we analyzed the hiPSCs, we found that patient-derived cells differentiated into fewer neurons and greater numbers of astrocytes. We then went further to determine the molecular mechanism underlying these changes in neurogenic and gliogenic competences."

When studying neuron differentiation from , scientists often generate neurospheres—clusters of cells in culture that contain and . The first thing the team noticed was that neurospheres from the patient-derived hiPSCs were on average 30% smaller than normal.

Since the cells in neurospheres can become neurons or glia—another type of brain cell—the team also looked at the proportions of neurons and glia that developed from the different groups of hiPSCs. They found that patient-derived neurospheres differentiated into 10% fewer neurons and about 13% more astrocytes—a type of glial cell—than normal.

The researchers then focused their investigation on the gene DGCR8 because it is located within the special region on chromosome 22, and when deleted in mice, also leads to smaller neurospheres. After confirming that DGCR8 expression was less in patient-derived neurospheres than in the controls, they showed that its deletion was associated with greater expression of the protein p38α, which is known to influence neural/glial competence of stem cells. Inhibition of p38α activity through inhibition of the protein MAPK14 increased the numbers of neurons that developed from patient-derived neurospheres and decreased the numbers of astrocytes.

To determine if this characteristic was true of schizophrenia in vivo, they examined the post-mortem brains of patients who had schizophrenia. They found that the frontal cortex of these brains contains significantly more markers for astrocytes and significantly fewer markers for neurons than the post-mortem brains of people without schizophrenia.

"We ameliorated the lower neurogenic-to-glicogenic competence using a MAPK14 inhibitor", notes Yoshikawa. "These results suggest that MAPK14 inhibitors might be an effective therapy if we could determine the appropriate time for administration, perhaps the early prodromal phase of schizophrenia."

However, Yoshikawa cautions that the molecular mechanisms discovered here may not apply to all cases of schizophrenia. "Our iPS cells from schizophrenia patients are perhaps a special case, because they included the genomic deletion from chromosome 22, which, through MAPK14, led to the imbalance in neuron/astrocyte development. However, there are likely other ways for the same type of imbalance to form in more general cases of ."

Explore further: Study implicates glial cells in fragile X syndrome

More information: Toshima M, Akamatsu W, Okada Y, Ohnishi T, Balan S, Hisano Y, Iwayama Y, Toyota T, Matsumoto T, Itasaka N, Sugiyama S, Tanaka M, Yano M, Dean B, Okano H, Yoshikawa T (2016). Analysis of induced pluripotent stem cells carrying 22q11.2 deletion. Translational Psychiatry. DOI: 10.1038/tp.2016.206

Related Stories

Study implicates glial cells in fragile X syndrome

October 4, 2016

Research on fragile X syndrome, the most common inherited cause of mental retardation, has focused mostly on how the genetic defect alters the functioning of neurons in the brain. A new study focusing on a different type ...

Team discovers neurochemical imbalance in schizophrenia

September 11, 2014

Using human induced pluripotent stem cells (hiPSCs), researchers at Skaggs School of Pharmacy and Pharmaceutical Sciences at University of California, San Diego have discovered that neurons from patients with schizophrenia ...

The brain's stunning genomic diversity revealed

September 12, 2016

Our brains contain a surprising diversity of DNA. Even though we are taught that every cell in our body has the same DNA, in fact most cells in the brain have changes to their DNA that make each neuron a little different.

Recommended for you

Chatter in the deep brain spurs empathy in rats

June 23, 2017

It's a classic conundrum: while rushing to get to an important meeting or appointment on time, you spot a stranger in distress. How do you decide whether to stop and help, or continue on your way?

The neural relationship between light and sleep

June 23, 2017

Humans are diurnal animals, meaning that we usually sleep at night and are awake during the day, due at least in part to light or the lack thereof. Light is known to affect sleep indirectly by entraining—modifying the length ...

How brains surrender to sleep

June 23, 2017

Scientists at the Research Institute of Molecular Pathology (IMP) in Vienna study fundamental aspects of sleep in roundworms. Using advanced technologies, they monitor the activity of all nerve cells in the brain while they ...

How pheromones trigger female sexual behavior

June 22, 2017

A study by a group of Japanese scientists showed how a male pheromone in mice enhances sexual behaviors in females—and how it may enhance a different behavior, aggression, in males—by identifying distinct neural circuits ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.